Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficiency of Eye Movement Desensitization and Reprocessing (EMDR) for the Treatment of Substance Use Disorders: A Randomized Controlled Trial

NCT03114423 is registered in ClinicalTrials.gov with Center of Integrative Addiction Research, Austria as lead sponsor.

NCT NCT03114423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03114423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficiency of Eye Movement Desensitization and Reprocessing (EMDR) for the Treatment of Substance Use Disorders: A Randomized Controlled Trial
Lead sponsor
Center of Integrative Addiction Research, Austria
Phase
Not applicable
Overall status
Unknown status
Start date
April 7, 2017
Completion date
July 31, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychotherapy, substance use disorders